ENTERPRISE THERAPEUTICS HOLDINGS LIMITED
Get an alert when ENTERPRISE THERAPEUTICS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2026-09-22 (in 4mo)
Last made up 2025-09-08
Watchouts
None on the register
Cash
£6M
-31.1% vs 2025
Net assets
£7M
-33.1% first positive since 2023
Employees
17
-5.6% vs 2025
Profit before tax
-£4M
+12.4% vs 2025
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · latest reflected 2025-12-31
| Metric | Trend | 2023-01-01 | 2023-12-31 | 2024-01-01 | 2024-12-31 | 2025-06-30 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | -£5,329,605 | -£4,614,054 | |
| Profit before tax | — | — | — | — | -£5,136,109 | -£4,496,978 | |
| Net profit | — | -£4,711,863 | — | -£14,469,567 | -£4,196,909 | -£3,741,553 | |
| Cash | — | £731,303 | — | £6,216,774 | £9,369,170 | £6,452,919 | |
| Total assets less current liabilities | — | — | — | — | £11,134,887 | £7,448,029 | |
| Net assets | — | -£5,645,372 | — | £6,199,860 | £11,134,887 | £7,448,029 | |
| Equity | -£951,845 | -£16,936,116 | -£5,645,372 | £18,599,580 | £11,134,887 | £7,448,029 | |
| Average employees | — | 17 | — | 18 | 18 | 17 | |
| Wages | — | — | — | — | £945,559 | £941,660 | |
| Directors' remuneration | — | — | — | — | £241,991 | £141,239 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2025 → FY2025 · period ending 2025-12-31 vs 2025-06-30
-
Turnover
—
Not reported
-
Cash
-31.1%
£9,369,170 £6,452,919
-
Net assets
-33.1%
£11,134,887 £7,448,029
first positive since 2023
-
Employees
-5.6%
18 17
-
Operating profit
+13.4%
-£5,329,605 -£4,614,054
-
Profit before tax
+12.4%
-£5,136,109 -£4,496,978
-
Wages
-0.4%
£945,559 £941,660
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-01-01 | 2023-12-31 | 2024-01-01 | 2024-12-31 | 2025-06-30 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Return on capital employed | — | — | — | — | -47.9% | -62.0% | |
| Gearing (liabilities / total assets) | — | 871.8% | — | 0.3% | 10.8% | 12.6% | |
| Current ratio | — | — | — | — | 9.20x | 7.95x | |
| Interest cover | — | — | — | — | -4729.02x | -42330.77x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- James Cowper Kreston Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis, which assumes that the Group will continue in operations for the foreseeable future. The Group has sufficient cash reserves for at least twelve months from the date of approval of the financial statements, and the Group has plans to undertake a further fundraising during 2026. The Directors, therefore, believe it is appropriate to adopt the going concern basis of accounting.”
Group structure
- ENTERPRISE THERAPEUTICS HOLDINGS LIMITED · parent
- Enterprise Therapeutics Limited 100%
- Enterprise Therapeutics Srl 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
10 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOYD, Philip James, Dr | Secretary | 2020-09-09 | — | — |
| DZIKOWSKI, Bart | Director | 2020-10-05 | Mar 1976 | Canadian |
| FINAN, Peter Michael, Dr | Director | 2020-10-05 | Jul 1967 | British |
| FORD, John William, Dr | Director | 2020-10-05 | Jul 1974 | British |
| HAMMOND, Janet Margaret Justine, Dr | Director | 2024-05-20 | Mar 1960 | American |
| MAYWEG, Alexander Volker, Dr | Director | 2020-10-05 | Mar 1975 | German |
| MULDER, Geert-Jan, Dr | Director | 2020-10-05 | Jul 1966 | Dutch |
| MUNSHI, Amit | Director | 2020-10-05 | Mar 1968 | American,Swiss |
| RICHARDSON, Johnathan Craig, Dr | Director | 2020-10-05 | Sep 1976 | British |
| WOODMAN, Robbie, Dr | Director | 2024-01-05 | Oct 1977 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOYD, Philip James, Dr | Director | 2020-09-09 | 2020-10-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Philip James Boyd | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-09-09 | Ceased 2020-10-05 |
Filing timeline
Last 20 of 61 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-02-18 RESOLUTIONS Resolution
- 2024-02-08 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-18 | AA | accounts | Accounts with accounts type group | |
| 2026-01-02 | AA01 | accounts | Change account reference date company previous shortened | |
| 2025-09-30 | SH01 | capital | Capital allotment shares | |
| 2025-09-15 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-09-15 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-08-06 | SH01 | capital | Capital allotment shares | |
| 2025-07-01 | AA01 | accounts | Change account reference date company previous shortened | |
| 2025-05-27 | AA | accounts | Accounts with accounts type full | |
| 2024-09-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-16 | CH01 | officers | Change person director company with change date | |
| 2024-07-04 | SH01 | capital | Capital allotment shares | |
| 2024-06-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | AA | accounts | Accounts with accounts type group | |
| 2024-02-18 | RESOLUTIONS | resolution | Resolution | |
| 2024-02-08 | MA | incorporation | Memorandum articles | |
| 2024-02-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-03 | SH01 | capital | Capital allotment shares | |
| 2024-02-01 | SH01 | capital | Capital allotment shares | |
| 2023-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.